Charles River Laboratories International, Inc. · NYSE:CRL
Coleman Glenn received 21,112 Charles River Laboratories International, Inc. shares as an award (Form 4)
Traded May 1, 2026 · Filed May 4, 2026
On May 1, 2026, Coleman Glenn (EVP & Chief Financial Officer) received 21,112 Charles River Laboratories International, Inc. shares as an award at US$165.78 for US$3.5M, leaving 21,112 shares. Filed May 4, 2026 (Form 4).
- Awarded
- 21,112 shares
- Price
- US$165.78
- Value
- US$3.5M
- Holding after
- 21,112 shares
- Trading plan
- No
- Role
- EVP & Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Award | 21,112 | US$165.78 | 21,112 | Direct |
Source
Related
- Charles River Laboratories International, Inc.
- Coleman Glenn
- Charles River Laboratories International, Inc. shareholders
- Form 4 · Coleman Glenn · Oct 2, 2026
- Form 4 · Coleman Glenn · Jun 2, 2026
- Form 4 · Parisotto Shannon M · Oct 7, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Form 4 · Foster James C · Aug 27, 2026
- Form 4 · Girshick Birgit · Aug 20, 2026
- Form 4 · Parisotto Shannon M · Aug 20, 2026